Literature DB >> 6347890

Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.

C J Liang-Takasaki, H Saxén, P H Mäkelä, L Leive.   

Abstract

Salmonellae with differences only in the O-antigenic polysaccharide of their lipopolysaccharide were previously shown to differentially activate complement via the alternative pathway, causing them to be ingested at different rates by the mouse macrophage-like cell line J774. We now show that this mechanism could explain the different virulence of these strains in vivo. Mouse peritoneal macrophages (thioglycolate induced) ingest these salmonellae at rates that are inversely proportional to the known virulence of the organisms and virtually identical to the rates observed with J774. As with J774, complement is required for this differential uptake, since serum was required and heating (56 degrees C for 30 min) or zymosan treatment of the serum destroyed activity. The known receptor for nonreducing terminal mannose-, fucose-, N-acetylglucosamine, and glucose-containing glyco-proteins did not participate, since uptake was not inhibited by high concentrations of mannan. When clearance of bacteria from the bloodstream of mice was measured, the least virulent organism was cleared very much faster than the most virulent organism, in confirmation of earlier data. When complement in the mice was destroyed by pretreatment with cobra venom factor, the clearance of the least virulent strain was greatly reduced, whereas the very slow clearance of the most virulent strain was unaffected. These data strongly support the hypothesis that when bacteria have polysaccharide in lipopolysaccharide that activates complement efficiently, the bacteria will be phagocytosed, whereas if the polysaccharide activates complement poorly, the bacteria escape ingestion and may cause disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347890      PMCID: PMC264679          DOI: 10.1128/iai.41.2.563-569.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  The kinetics of blood clearance o isotopically labelled Salmonella entertidis by the reticulo-endothelial system in mice.

Authors:  G BIOZZI; J G HOWARD; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Immunology       Date:  1960-01       Impact factor: 7.397

2.  Sensitization of complement-resistant smooth gram-negative bacterial strains.

Authors:  B L Reynolds; H Pruul
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

3.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

Review 4.  Bacterial virulence factors--with particular reference to Salmonella bacteria.

Authors:  A A Lindberg
Journal:  Scand J Infect Dis Suppl       Date:  1980

5.  Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis.

Authors:  M V Valtonen; M Plosila; V V Valtonen; P H Mäkelä
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

6.  Fimbriae and infectivity in Salmonella typhimurium.

Authors:  J P Duguid; M R Darekar; D W Wheater
Journal:  J Med Microbiol       Date:  1976-11       Impact factor: 2.472

7.  Role of phagocytosis in mouse virulence of Salmonella typhimurium recombinants with O antigen 6,7 or 4,12.

Authors:  M V Valtonen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  A sensitive microassay for the murine alternative complement pathway.

Authors:  K A Joiner; R Shahon; J A Gelfand
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  Immunochemical studies on Salmonella. 13. Chemical changes appearing on the specific polysaccharide of S. cholerae suis (6-2,7) after its conversion by phage 14(6,7).

Authors:  N A Fuller; A M Staub
Journal:  Eur J Biochem       Date:  1968-04

10.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

View more
  25 in total

1.  The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.

Authors:  F Nishikawa; S Yoshikawa; H Harada; M Kita; E Kita
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

2.  Identification and characterization of a phase-variable nonfimbrial Salmonella typhimurium gene that alters O-antigen production.

Authors:  L Y Kwan; R E Isaacson
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 3.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 4.  Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Authors:  Raphael Simon; Myron M Levine
Journal:  Hum Vaccin Immunother       Date:  2012-02-28       Impact factor: 3.452

5.  Genomic basis of endosymbiont-conferred protection against an insect parasitoid.

Authors:  Allison K Hansen; Christoph Vorburger; Nancy A Moran
Journal:  Genome Res       Date:  2011-09-23       Impact factor: 9.043

Review 6.  Genetic susceptibility to invasive Salmonella disease.

Authors:  James J Gilchrist; Calman A MacLennan; Adrian V S Hill
Journal:  Nat Rev Immunol       Date:  2015-07       Impact factor: 53.106

Review 7.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.

Authors:  Yun Shan Goh; Kathryn L Armour; Michael R Clark; Andrew J Grant; Pietro Mastroeni
Journal:  J Vaccines Vaccin       Date:  2016-05-30

9.  Activation of complement system by porins extracted from Salmonella typhimurium.

Authors:  F Galdiero; M A Tufano; L Sommese; A Folgore; F Tedesco
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.

Authors:  R W Vreede; J H Marcelis; J Verhoef
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.